Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$0.63 - $1.59 $207,932 - $524,782
-330,052 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$2.89 - $4.45 $84,359 - $129,895
29,190 Added 9.7%
330,052 $1.24 Million
Q1 2021

May 14, 2021

SELL
$2.9 - $4.09 $63,133 - $89,039
-21,770 Reduced 6.75%
300,862 $981,000
Q3 2020

Nov 13, 2020

BUY
$2.99 - $4.9 $208,044 - $340,942
69,580 Added 27.5%
322,632 $1.32 Million
Q4 2019

Feb 14, 2020

SELL
$3.5 - $10.35 $116,900 - $345,690
-33,400 Reduced 11.66%
253,052 $921,000
Q3 2019

Nov 14, 2019

BUY
$7.03 - $9.7 $364,519 - $502,964
51,852 Added 22.1%
286,452 $2.38 Million
Q2 2019

Aug 14, 2019

BUY
$7.36 - $11.26 $1.04 Million - $1.59 Million
141,200 Added 151.18%
234,600 $2.02 Million
Q1 2019

May 14, 2019

BUY
$9.08 - $11.84 $60,836 - $79,328
6,700 Added 7.73%
93,400 $998,000
Q4 2018

Feb 14, 2019

BUY
$6.39 - $16.99 $116,298 - $309,218
18,200 Added 26.57%
86,700 $759,000
Q3 2018

Nov 14, 2018

BUY
$16.52 - $24.82 $129,252 - $194,191
7,824 Added 12.89%
68,500 $1.15 Million
Q2 2018

Aug 14, 2018

BUY
$14.31 - $21.75 $30,051 - $45,675
2,100 Added 3.59%
60,676 $1.27 Million
Q1 2018

May 10, 2018

SELL
$16.09 - $23.07 $534,188 - $765,924
-33,200 Reduced 36.18%
58,576 $942,000
Q4 2017

Feb 02, 2018

BUY
$13.36 - $20.73 $597,192 - $926,631
44,700 Added 94.95%
91,776 $1.74 Million
Q3 2017

Nov 14, 2017

BUY
$8.75 - $14.07 $411,915 - $662,359
47,076
47,076 $0

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0

About SPECTRUM PHARMACEUTICALS INC


  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track Public Sector Pension Investment Board Portfolio

Follow Public Sector Pension Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Public Sector Pension Investment Board with notifications on news.